News

A new state of the art technology to better understand your drug substance and drug product is now available at Delpharm Development Leiden

World-leading CDMO Delpharm expands its pharmaceutical network with the acquisition from Astellas of the Meppel pharmaceutical manufacturing facility.

Delpharm is able to support your microsphere projects with development from scratch to commercial manufacturing through IMP (Investigational Medicinal Product) manufacturing.

Hand in hand collaboration and team spirit between each partner leads to a successful projects : making clinical batches available in a record time of patients.

Delpharm differentiates itself and adapts to the current and future needs of its customers with prefilled syringe dosage form.

Delpharm expands its pharmaceutical development services with the acquisition of an injectable drug development centre in the Netherlands.